Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of SuccessGBI ResearchJanuary 16, 2012 152 Pages - SKU: XGBR6768939 |
Enter a term to search inside this document.
|
Use the same search language as you do when searching for reports Search terms are implicitly ORed together. This means that a search for Bottled Water is equivalent to a search for Bottled OR Water. In this scenario, only sections that contain either the word 'Bottled' or the word 'Water' will have ""Keywords in Context"" results. To find sections that contain all of the search terms, separate the search terms with 'AND' ex Bottled AND Water |
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Cardiovascular Reports
- MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Current and Future Players
- MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts
- MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - South America Analysis and Market Forecasts
- MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - US Analysis and Market Forecasts
- Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] – Global Forecasts to 2017